Apple’s crucial new iPhone warning about potential health risk

Apple is putting out a warning to all Apple iphone consumers who have pacemakers or other implanted clinical units to make certain that they are trying to keep their units at least six inches absent from their chests. 

Here’s what we know so considerably.

Click on TO GET KURT’S CYBERGUY Newsletter WITH Rapid Recommendations, TECH Evaluations, Safety ALERTS AND Straightforward HOW-TO’S TO MAKE YOU SMARTER

Why really should I retain my Apple iphone absent from my chest?

The motive Apple is putting this discover out for persons with pacemakers is that the magnets and electromagnetic fields inside of an Iphone product may perhaps interfere with the machines’ functions.

Apple to start with began putting out warnings like this in Oct 2020 when the American Heart Association warned about the magnets within just the Iphone 12 devices. The magnets in these products had been potent adequate to modify the timing of the pacemaker or even deactivate a defibrillator’s features, which could set a human being with a pacemaker at danger for heart failure or a stroke.

Apple’s crucial new iPhone warning about potential health risk

Persons with pacemakers should really hold their Apple equipment away from their chests, the firm warns. (CyberGuy.com)

ARE YOUR Techniques Fully OFF FOR YOUR 2023 Conditioning Goals?

What other units need to I maintain at a distance?

If you happen to be anyone with a pacemaker, you ought to continue to keep the pursuing units at a distance from your upper body as they have magnets or factors and radios that emit electromagnetic fields.

AirPods and scenarios

  • AirPods and charging case
  • AirPods Professional and charging situation
  • AirPods Max and Good Scenario

Apple Look at and add-ons

  • Apple Look at
  • Apple Check out bands with magnets
  • Apple Observe magnetic charging components

HomePod

iPad and equipment

  • iPad
  • iPad mini
  • iPad Air
  • iPad Professional
  • iPad Wise Handles and Smart Folios
  • iPad Good Keyboard and Sensible Keyboard Folio
  • Magic Keyboard Folio
  • Magic Keyboard for iPad

VOICE CLONING IS THE NEW WEAPON IN SCAMMERS’ ARSENAL FOR Relatives Unexpected emergency Schemes

Iphone and MagSafe add-ons

Mac and add-ons

  • Mac mini
  • Mac Professional
  • MacBook Air
  • MacBook Pro
  • iMac
  • Apple Pro Display XDR

Beats

  • Beats Flex
  • Beats Studio Buds
  • BeatsX
  • Powerbeats Pro
  • UrBeats3

THE MOST Critical SOS Tool At any time Designed

What if the font is far too compact for me at a distance?

If you have to maintain your Iphone at a distance however then battle to read what’s on your monitor, you can alter the dimension of your font by next these steps.

  • Open up your Settings app
  • Click on Screen & Brightness 
  • Tap Textual content Size 
  • Use the slider at the base to alter the measurement of your font

Do you have other tips for trying to keep your Iphone at a length? Allow us know under.

Simply click Listed here TO GET THE FOX News App

For much more of my guidelines, subscribe to my free of charge CyberGuy Report E-newsletter by viewing CyberGuy.com/Newsletter. 

Copyright 2023 CyberGuy.com. All rights reserved.  

AI language models open a potential Pandora’s box of medical research fraud

AI language models open a potential Pandora’s box of medical research fraud
Credit: Unsplash/CC0 Public Domain

Medical student and researcher Faisal Elali of the State University of New York Downstate Health Sciences University and medical scribe and researcher Leena Rachid from the New York-Presbyterian/Weill Cornell Medical Center wanted to see if artificial intelligence could write a fabricated research paper and then investigate how best to detect it.

Artificial intelligence is an increasingly valuable and vital part of scientific research. It is used as a tool to analyze complicated data sets, but it is never used to generate the actual paper for publication. AI-generated research papers, on the other hand, can look convincing even when based on an entirely fabricated study. But exactly how convincing?

In a paper published in the open-access journal Patterns, the research duo demonstrated the feasibility of fabricating a research paper using ChatGPT, an AI-based language model. Simply by asking, they were able to have ChatGPT produce a number of well-written, entirely made-up abstracts. A hypothetical fraudster could then submit these fake abstracts to multiple journals seeking publication. If accepted, the same process could be used to write an entire study with false data, nonexistent participants and meaningless results. However, it could appear legitimate, especially if the subject is particularly abstract or not screened by an expert in the specific field.

In a previous experiment cited in the current paper, humans were given both human-created and AI-generated abstracts to consider. In that experiment, humans incorrectly identified 32{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of the AI-generated research abstracts as real and 14{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of the human-written abstracts as fake.

The current research team decided to test their ChatGPT fabricated study against three online AI detectors. The texts were overwhelmingly identified as AI-generated, suggesting the adoption of AI detection tools by journals could be a successful diverter of fraudulent applications. However, when they took the same text and ran it through a free, online, AI-powered rephrasing tool first—the consensus unanimously flipped to “likely human,” suggesting we need better AI detection tools.

Actual science is hard work, and communicating the details of that work is a crucial aspect of science requiring substantial effort. But any mostly hairless ape can string sensible sounding words together given enough time and coffee—as the writer of this article can firmly attest. Creating a fake study with enough detail to seem credible would take tremendous effort, requiring hours of researching how best to sound believable, and might be too tedious a task for someone interested in malicious mischief. With AI completing the task in minutes, that mischief could become an entirely achievable objective. As the researchers point out in their paper, that mischief could have terrible consequences.

They give an example of a legitimate study that supports the use of drug A over drug B for treating a medical condition. Now, suppose a fabricated study makes the opposite claim and is not detected (as a side note, even if it is detected, clawing back citations and reprints of retracted studies is notoriously difficult). It could impact subsequent meta-analyses and systematic reviews of these studies—studies that guide health care policies, standards of care and clinical recommendations.

Beyond the simple mischief motive, the authors of the paper point to the pressure on medical professionals to quickly produce a high volume of publications to gain research funding or entry into higher career positions. In part, they point out that the United States Medical Licensing Examination recently switched from a graded exam to a pass/fail model, meaning ambitious students rely more heavily on published research to distinguish them from the pack. This raises the stakes for a trustworthy AI detection system to remove potentially fraudulent medical research that could pollute the publishing environment—or worse still, practitioners who submit fraudulent papers from practicing on patients.

The goal of AI language models has long been to produce texts that are indistinguishable from human text. That we need AI that can detect when a human is using AI to produce fraudulent work indistinguishable from reality should not come as a surprise. What might be surprising is just that we may need it so soon.

More information:
Faisal R. Elali et al, AI-generated research paper fabrication and plagiarism in the scientific community, Patterns (2023). DOI: 10.1016/j.patter.2023.100706

© 2023 Science X Network

Citation:
AI language models open a potential Pandora’s box of medical research fraud (2023, March 14)
retrieved 14 March 2023
from https://medicalxpress.com/news/2023-03-ai-language-potential-pandora-medical.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

3 Medical Instruments Stocks With Potential to Outperform

In recent years, the medical instrument industry, part of the wider Medical sector, has seen a transformation in the nature of its business, leading to higher research and development activities for developing cutting-edge technologies. The industry’s landscape changed further with the onset of the COVID-19 crisis that put robotic and remote services in the limelight. Although the majority of economies have opened up following strict lockdowns in the past couple of years, the demand for robotic and remote services is likely to remain.

However, the industry is currently facing several challenges, including supply-chain challenges, a shortage of semiconductor chips and global inflationary pressure. These developments have resulted in an extremely tough situation related to raw material and labor costs as well as freight charges. The shortage of semiconductor chips has resulted in a delay in the production of commercialized products.

Although the industry faced headwinds, a few medical instrument companies were able to maintain their recovery trend in the first nine months of 2022. Moreover, the ongoing macro headwinds are likely to improve in 2023, which should help top-line and bottom-line growth.

Here we discuss three medical instruments stocks — ShockWave Medical SWAV, iRadimed IRMD and Tactile Systems Technology TCMD — which are likely to outperform the industry going forward amid an improving world economy and easing macro headwinds. These stocks carry a Zacks Rank #2 (Buy) each. These stocks also have a Momentum Score of A or B, which indicates that these would be good stocks for momentum investors based on recent price changes and earnings estimate revisions. Meanwhile, the underperformance of iRadimed and Tactile Systems in the past six months compared with the Zacks Medical – Instruments industry may lead to a rally in these stocks on the back of strong fundamentals. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

3 Medical Instruments Stocks With Potential to Outperform
Image Source: Zacks Investment Research

ShockWave Medical

ShockWave Medical has a Momentum Score of B. The Zacks Consensus Estimate for earnings has moved 12.1{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} and 4.1{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} north for 2022 and 2023, respectively, in the past 60 days.

The increased adoption of coronary IVL in the United States, continued sales force expansion, growing international expansion and higher adoption of Shockwave products are likely to boost the company’s performance. The company’s strong global growth highlights the significant clinical need for a better calcium treatment and how well the team at ShockWave Medical is addressing the same with IVL.

ShockWave Medical, Inc. Price

ShockWave Medical, Inc. Price

ShockWave Medical, Inc. price | ShockWave Medical, Inc. Quote

iRadimed

iRadimed has a Momentum Score of B. The Zacks Consensus Estimate for earnings has improved 2.9{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} for 2022 in the past 60 days. The consensus estimate for 2023 earnings stands at $1.20 per share, implying year-over-year growth of 13.2{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f}.

iRadimed is a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system and non-magnetic patient vital signs monitoring systems designed for use during MRI procedures. During the third quarter, the company reported 23{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} growth in revenues and 35{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} in earnings from the year-ago period. The company stated that significant demand for its IV pump and patient monitor product lines continued during the third quarter. The company has a strong bookings growth that continued to add to its extensive backlog and is likely to drive revenues for the remainder of 2022 and 2023.

iRadimed Corporation Price

iRadimed Corporation Price

iRadimed Corporation price | iRadimed Corporation Quote

Tactile Systems

Tactile Systems has a Momentum Score of A. The Zacks Consensus Estimate for loss has narrowed 12.6{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} for 2022. The consensus estimates for 2023 loss stood at 10 cents, implying a year-over-year improvement of 87.3{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f}.

The medical technology company develops medical devices for the treatment of chronic diseases at home. During the third quarter, it reported 24{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} growth in revenues and loss narrowed 35.3{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} year over year. Strong demand for its products during the quarter led the company to raise its revenue guidance by approximately 1.5{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} as measured at the midpoint of the guided ranges. Meanwhile, its settlement of a pending securities class action lawsuit earlier this month removed an overhang.

Tactile Systems Technology, Inc. Price

Tactile Systems Technology, Inc. Price

Tactile Systems Technology, Inc. price | Tactile Systems Technology, Inc. Quote

Zacks Names “Single Best Pick to Double”

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} in little more than 9 months and NVIDIA which boomed +175.9{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} in one year.

Free: See Our Top Stock and 4 Runners Up >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

iRadimed Corporation (IRMD) : Free Stock Analysis Report

Tactile Systems Technology, Inc. (TCMD) : Free Stock Analysis Report

ShockWave Medical, Inc. (SWAV) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.